Literature DB >> 25924722

Association between Oxidative Stress and Frailty in an Elderly German Population: Results from the ESTHER Cohort Study.

Kai-Uwe Saum1, Aida Karina Dieffenbach, Eugène H J M Jansen, Ben Schöttker, Bernd Holleczek, Klaus Hauer, Hermann Brenner.   

Abstract

BACKGROUND: Oxidative stress (OS) and inflammatory biomarkers have been postulated to be important factors in the development of age-related diseases. While causes of frailty are complex and multidimensional based on the interaction of genetic, biological, physical, and environmental factors, the biological basis of frailty has been difficult to establish.
OBJECTIVE: In this study, we aimed to assess the possible association between different OS and inflammatory biomarkers and frailty.
METHODS: This cross-sectional analysis was performed among 2,518 subjects participating in a large population-based cohort study on aging conducted in Germany. Frailty was assessed as proposed by Fried et al. [J Gerontol A Biol Sci Med Sci 2001;56:M146-M156]. OS biomarkers, biological antioxidant potential (BAP), derivate of reactive oxygen metabolites (d-ROM) and total thiol levels (TTL), and an established biomarker of inflammation C-reactive protein (CRP) were measured by spectrophotometry and immunoturbidimetry. Logistic regression models were performed to assess the relationship between the OS biomarkers and frailty status. Odds ratios (OR) and 95% confidence intervals (CI) were calculated to quantify the associations.
RESULTS: Mean levels of d-ROM, TTL, and CRP differed between frail and non-frail participants (p values <0.0001). Comparing highest and lowest quartiles of the biomarkers, statistically significant positive associations with frailty were observed for d-ROM (OR: 2.02, 95% CI: 1.25-3.25) and CRP (OR: 3.15, 95% CI: 2.00-4.96), respectively, after controlling for age and sex. An inverse statistically significant association with frailty was observed for TTL (OR: 0.42, 95% CI: 0.25-0.69).
CONCLUSION: The strong associations with OS biomarkers and CRP support a major role of OS and inflammation in the development of frailty, which should be followed up in further longitudinal studies on frailty.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25924722     DOI: 10.1159/000380881

Source DB:  PubMed          Journal:  Gerontology        ISSN: 0304-324X            Impact factor:   5.140


  27 in total

Review 1.  Frailty biomarkers in humans and rodents: Current approaches and future advances.

Authors:  Alice E Kane; David A Sinclair
Journal:  Mech Ageing Dev       Date:  2019-04-17       Impact factor: 5.432

Review 2.  Physiological Systems in Promoting Frailty.

Authors:  Laís R Perazza; Holly M Brown-Borg; LaDora V Thompson
Journal:  Compr Physiol       Date:  2022-04-26       Impact factor: 8.915

Review 3.  Inflammaging and Frailty in Immune-Mediated Rheumatic Diseases: How to Address and Score the Issue.

Authors:  Fausto Salaffi; Andrea Di Matteo; Sonia Farah; Marco Di Carlo
Journal:  Clin Rev Allergy Immunol       Date:  2022-05-21       Impact factor: 10.817

Review 4.  Frailty: Past, present, and future?

Authors:  Dongmin Kwak; LaDora V Thompson
Journal:  Sports Med Health Sci       Date:  2020-11-30

Review 5.  Inflammatory biomarkers in older adults with frailty: a systematic review and meta-analysis of cross-sectional studies.

Authors:  YuShuang Xu; MengMeng Wang; Di Chen; Xin Jiang; ZhiFan Xiong
Journal:  Aging Clin Exp Res       Date:  2022-01-04       Impact factor: 4.481

Review 6.  Association of inflammatory mediators with frailty status in older adults: results from a systematic review and meta-analysis.

Authors:  Diego Marcos-Pérez; María Sánchez-Flores; Stefania Proietti; Stefano Bonassi; Solange Costa; Joao Paulo Teixeira; Juan Fernández-Tajes; Eduardo Pásaro; Blanca Laffon; Vanessa Valdiglesias
Journal:  Geroscience       Date:  2020-08-15       Impact factor: 7.713

7.  Risk Factors of Progression to Frailty: Findings from the Singapore Longitudinal Ageing Study.

Authors:  C Y Cheong; M S Z Nyunt; Q Gao; X Gwee; R W M Choo; K B Yap; S L Wee; T P Ng
Journal:  J Nutr Health Aging       Date:  2020       Impact factor: 4.075

8.  Frailty Phenotype and Cause-Specific Mortality in the United States.

Authors:  Matthew C Lohman; Amanda J Sonnega; Nicholas V Resciniti; Amanda N Leggett
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2020-09-25       Impact factor: 6.053

9.  Epigenetic age acceleration predicts cancer, cardiovascular, and all-cause mortality in a German case cohort.

Authors:  Laura Perna; Yan Zhang; Ute Mons; Bernd Holleczek; Kai-Uwe Saum; Hermann Brenner
Journal:  Clin Epigenetics       Date:  2016-06-03       Impact factor: 6.551

10.  Prevalence of Hypovitaminosis C and its Relationship with Frailty in Older Hospitalised Patients: A Cross-Sectional Study.

Authors:  Yogesh Sharma; Alexandra Popescu; Chris Horwood; Paul Hakendorf; Campbell Thompson
Journal:  Nutrients       Date:  2021-06-20       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.